Aliases & Classifications for Farsightedness

MalaCards integrated aliases for Farsightedness:

Name: Farsightedness 43
Hypermetropia 43 29 6 32
Hyperopia 43 54
Long-Sightedness 43
Far-Sightedness 43
Long-Sighted 43
Farsighted 43

Classifications:



External Ids:

ICD10 32 H52.0

Summaries for Farsightedness

MedlinePlus Genetics : 43 Farsightedness, also known as hyperopia, is an eye condition that causes blurry near vision. People who are farsighted have more trouble seeing things that are close up (such as when reading or using a computer) than things that are far away (such as when driving).For normal vision, light passes through the clear cornea at the front of the eye and is focused by the lens onto the surface of the retina, which is the lining of the back of the eye that contains light-sensing cells. Some people who are farsighted have eyeballs that are too short from front to back. Others have a cornea or lens that is abnormally shaped. These changes cause light entering the eye to be focused too far back, behind the retina instead of on its surface. It is this difference that causes nearby objects to appear blurry. In a person with this condition, one eye may be more farsighted than the other.If it is not treated with corrective lenses or surgery, farsightedness can lead to eye strain, excess tearing, squinting, frequent blinking, headaches, difficulty reading, and problems with hand-eye coordination. However, some children with the eye changes characteristic of farsightedness do not notice any blurring of their vision or related signs and symptoms early in life. Other parts of the visual system are able to compensate, at least temporarily, for the changes that would otherwise cause light to be focused in the wrong place.Most infants are born with a mild degree of farsightedness, which goes away on its own as the eyes grow. In some children, farsightedness persists or is more severe. Children with a severe degree of farsightedness, described as high hyperopia, are at an increased risk of developing other eye conditions, particularly "lazy eye" (amblyopia) and eyes that do not look in the same direction (strabismus). These conditions can cause significant visual impairment.In general, older adults also have difficulty seeing things close up; this condition is known as presbyopia. Presbyopia develops as the lens of the eye becomes thicker and less flexible with age and the muscles surrounding the lens weaken. Although it is sometimes described as "farsightedness," presbyopia is caused by a different mechanism than hyperopia and is considered a separate condition.

MalaCards based summary : Farsightedness, also known as hypermetropia, is related to hypertelorism and cryptorchidism, unilateral or bilateral. An important gene associated with Farsightedness is ANKRD11 (Ankyrin Repeat Domain 11). The drugs Nepafenac and Ketorolac have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and endothelial.

Wikipedia : 73 Far-sightedness, also known as long-sightedness, hypermetropia, or hyperopia, is a condition of the eye... more...

Related Diseases for Farsightedness

Diseases related to Farsightedness via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 192)
# Related Disease Score Top Affiliating Genes
1 hypertelorism 29.3 NSD1 FGF14 ANKRD11
2 cryptorchidism, unilateral or bilateral 29.2 NSD1 FGF14 ANKRD11
3 stapes ankylosis with broad thumbs and toes 11.3
4 pilodental dysplasia with refractive errors 11.2
5 leber plus disease 11.1
6 cornea plana 2, autosomal recessive 11.0
7 leber congenital amaurosis 6 11.0
8 senior-loken syndrome 1 11.0
9 nanophthalmos 4 11.0
10 microphthalmia 11.0
11 leber congenital amaurosis 10 10.9
12 leber congenital amaurosis 13 10.9
13 hyperopia, high 10.9
14 microphthalmia with hyperopia, retinal degeneration, macrophakia, and dental anomalies 10.9
15 syndromic hyperopia 10.9
16 rare hyperopia and astigmatism 10.9
17 nanophthalmos 10.9
18 microphthalmia, isolated 1 10.9
19 kenny-caffey syndrome, type 2 10.9
20 vitreoretinochoroidopathy 10.9
21 leber congenital amaurosis 1 10.9
22 leber congenital amaurosis 2 10.9
23 kenny-caffey syndrome, type 1 10.9
24 retinitis pigmentosa 12 10.9
25 microphthalmia, isolated 5 10.9
26 leber congenital amaurosis 7 10.9
27 leber congenital amaurosis 8 10.9
28 leber congenital amaurosis 11 10.9
29 familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis 10.9
30 blepharophimosis, ptosis, and epicanthus inversus 10.8
31 myhre syndrome 10.8
32 microcephalic osteodysplastic primordial dwarfism, type ii 10.8
33 achromatopsia 2 10.8
34 kaufman oculocerebrofacial syndrome 10.8
35 retinoschisis 1, x-linked, juvenile 10.8
36 fontaine progeroid syndrome 10.8
37 helsmoortel-van der aa syndrome 10.8
38 white-sutton syndrome 10.8
39 snijders blok-campeau syndrome 10.8
40 amblyopia 10.8
41 achromatopsia 10.8
42 refractive error 10.8
43 hivep2-related intellectual disability 10.8
44 night blindness, congenital stationary, type 1a 10.8
45 nanophthalmos 2 10.8
46 cornea plana 1, autosomal dominant 10.8
47 retinal degeneration with nanophthalmos, cystic macular degeneration, and angle closure glaucoma 10.8
48 leber congenital amaurosis 3 10.8
49 leber congenital amaurosis 4 10.8
50 leber congenital amaurosis 5 10.8

Graphical network of the top 20 diseases related to Farsightedness:



Diseases related to Farsightedness

Symptoms & Phenotypes for Farsightedness

Drugs & Therapeutics for Farsightedness

Drugs for Farsightedness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 56)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nepafenac Approved, Investigational Phase 4 78281-72-8 151075
2
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
3
Propoxycaine Approved Phase 4 86-43-1
4 Pharmaceutical Solutions Phase 4
5 Anti-Inflammatory Agents Phase 4
6 Analgesics, Non-Narcotic Phase 4
7 Cyclooxygenase Inhibitors Phase 4
8 Analgesics Phase 4
9 Antirheumatic Agents Phase 4
10 Ketorolac Tromethamine Phase 4
11 Anti-Inflammatory Agents, Non-Steroidal Phase 4
12 Anesthetics Phase 4
13 Anesthetics, Local Phase 4
14 Proxymetacaine Phase 4
15
Ofloxacin Approved Phase 1, Phase 2 82419-36-1 4583
16
Levofloxacin Approved, Investigational Phase 1, Phase 2 100986-85-4 149096
17
Betamethasone Approved, Vet_approved Phase 1, Phase 2 378-44-9 9782
18
Folic acid Approved, Nutraceutical, Vet_approved Phase 1, Phase 2 59-30-3 6037
19
Riboflavin Approved, Investigational, Nutraceutical, Vet_approved Phase 1, Phase 2 83-88-5 493570
20 Antibiotics, Antitubercular Phase 1, Phase 2
21 Anti-Bacterial Agents Phase 1, Phase 2
22 Anti-Infective Agents Phase 1, Phase 2
23 Anti-Asthmatic Agents Phase 1, Phase 2
24 Respiratory System Agents Phase 1, Phase 2
25 Cytochrome P-450 Enzyme Inhibitors Phase 1, Phase 2
26 Hormone Antagonists Phase 1, Phase 2
27 Hormones Phase 1, Phase 2
28 glucocorticoids Phase 1, Phase 2
29 Vitamin B9 Phase 1, Phase 2
30 Nutrients Phase 1, Phase 2
31 Micronutrients Phase 1, Phase 2
32 Trace Elements Phase 1, Phase 2
33 Ophthalmic Solutions Phase 1, Phase 2
34 Anticoagulants Phase 1, Phase 2
35 Photosensitizing Agents Phase 1, Phase 2
36 Vitamin B Complex Phase 1, Phase 2
37 Vitamins Phase 1, Phase 2
38 Folate Phase 1, Phase 2
39 Vitamin B2 Phase 1, Phase 2
40 Plasma Substitutes Phase 1, Phase 2
41 Dermatologic Agents Phase 1, Phase 2
42 Dextrans Phase 1, Phase 2
43 Blood Substitutes Phase 1, Phase 2
44
Phenylephrine Approved 59-42-7 6041
45
Tropicamide Approved, Investigational 1508-75-4 5593
46
Oxymetazoline Approved, Investigational 1491-59-4 4636
47
Coal tar Approved 8007-45-2
48
Hydrogen peroxide Approved, Vet_approved 7722-84-1 784
49 Mitomycins
50 Contact Lens Solutions

Interventional clinical trials:

(show top 50) (show all 103)
# Name Status NCT ID Phase Drugs
1 PHASE IV STUDY # 1162. Prospective Investigation of SUPRACOR Visual Outcomes of Presbyopic Hyperopic Patients With and Without Astigmatism Unknown status NCT01628146 Phase 4
2 A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK Unknown status NCT02071576 Phase 4
3 A Prospective Safety and Effectiveness Study of a New High Repetition Rate Excimer Laser Using LASIK for the Correction of Ammetropia and Presbyopia Unknown status NCT02112968 Phase 4
4 A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIK Unknown status NCT01977807 Phase 4
5 On-Eye Optical Quality of Lotrafilcon B Lenses Over 12 Hours Completed NCT03881670 Phase 4
6 Corneal and Conjunctival Sensitivity and Staining Study Completed NCT00455455 Phase 4 Optifree RepleniSH Multipurpose Disinfecting Solution;ReNu Multiplus Multipurpose Solution
7 Double Masked Evaluation of Acular LS Versus Nevanac for Postoperative Pain Control in Eyes Undergoing PRK Completed NCT00347204 Phase 4 ketorolac (Acular LS);Nepafenac (Nevanac)
8 A Prospective Study to Evaluate the Safety and Effectiveness of the Supracor Presbyopic Treatment Algorithm for Pseudophakic Eyes Using Lasik Completed NCT01387360 Phase 4
9 Clinical Investigation of the Vision-R800 Device. Understanding the Value of High Precision Refractions and Lenses to Optometrists and Patients. Phase 2 Completed NCT04208750 Phase 4
10 Infiltrative Events During Silicone Hydrogel Daily Contact Lens (Daily Wear Corneal Infiltrative Event (DWCIE) Study) Completed NCT00937105 Phase 4
11 Efficacy and Safety of Anesthetic Impregnated Bandage Soft Contact Lens (BSCL) in Pain Management After Photorefractive Keratectomy (PRK). Recruiting NCT04283331 Phase 4 Proparacaine Ophthalmic
12 Intrastromal Correction of Ametropia by a Femtosecond Laser Unknown status NCT00928122 Phase 3
13 A Prospective Multicenter, Study to Evaluate the Safety and Effectiveness of the Presbyopia Algorithm for Hyperopia and Hyperopic Astigmatism Using LASIK Completed NCT00910403 Phase 3
14 A Prospective Study to Evaluate the Safety and Effectiveness of the Presbyopic LASIK Algorithm Completed NCT01322919 Phase 3
15 Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors Completed NCT01028378 Phase 3
16 Multipurpose Solution Compatibility With a Silicone Hydrogel Lens Completed NCT00520689 Phase 3
17 Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation Unknown status NCT02148016 Phase 1, Phase 2 Levofloxacin;Betamethasone;Limbal stem cells (LSCs)
18 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions Completed NCT01024855 Phase 1, Phase 2
19 A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of LASIK With Cross-linking Performed With the KXL System and Photrexa ZD™ (Riboflavin Ophthalmic Solution) Compared to LASIK Alone for Hyperopia and Hyperopic Astigmatism Terminated NCT01893359 Phase 1, Phase 2 riboflavin ophthalmic solution, 0% dextran
20 Enhancement of Emmetropization in Hyperopic Infants Terminated NCT00574717 Phase 1, Phase 2
21 Prospective, Single-center Clinical Trial of Subjects Scheduled to Undergo LASIK Surgery Requiring an Initial Corneal Flap. Completed NCT01556893 Phase 1
22 Posterior and Anterior Ocular Imaging With Spectral Domain Optical Coherence Tomography Unknown status NCT00926549
23 A 180 Day, Multicenter Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses for Daily Wear Use in the Correction of Refractive Error With or Without Astigmatism in Non-diseased Eyes Unknown status NCT01058629
24 Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction Unknown status NCT02316041
25 Study to Evaluate the Safety and Efficacy of HI-BRITE Large Diameter Rigid Gas Permeable Contact Lens (Hexafocon b) Test When Worn on a Daily Wear Basis in the Correction of Myopia/Hyperopia/Astigmatism/Presbyopia/ and Irregular Cornea. Unknown status NCT02812316
26 Comparison of Small Incision Lenticule Extraction (SMILE) and VisuMax Femtosecond Laser In Situ Keratomileusis (FemtoLASIK): A Randomized, Non-inferiority Trial Unknown status NCT01216475
27 Development of a Validated Chart for Intermediate Vision Assessment Unknown status NCT02279446
28 A Combined Retrospective and Prospective Chart Review Analysis of Visual Outcomes Following Excimer Laser Vision Correction Unknown status NCT00778570
29 A Prospective, Global, Multi-Center Study for the Evaluation of Outcomes on Subjects Undergoing Myopic Treatments Using the WaveLight® Refractive Suite Completed NCT01941498
30 Randomized Controlled, Double-Blind Trial of Investigation of the Effect of Different Eye Exercises on Hypermetropia in School-age Children Completed NCT03347734
31 Shanghai Guanghua Integrated Traditional Chinese and Western Medicine Hospital, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China Completed NCT04666870
32 Visual Performance Investigation of Two Toric Soft Contact Lenses Completed NCT01858701
33 An Open-Labeled, Multi-Center, Randomized Investigation of the VISA (Comfilcon A) Silicone Hydrogel Soft (Hydrophilic) Contact Lens for Use in a 7 Day Extended Wear Regimen Completed NCT00597467
34 Corneal Wavefront-Guided PRK With Adjunctive Mitomycin-C for the Treatment of Hyperopia After Radial Keratotomy Completed NCT00917657
35 Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution Completed NCT01809197
36 Clinical Performance of Two Daily Disposable Contact Lenses - Study 1 Completed NCT03969290
37 Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses Completed NCT04254003
38 Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment With High Astigmatism and Hyperopia Completed NCT04468022
39 A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia Completed NCT00348205
40 Thin-Flap Laser in Situ Keratomileusis Associated Dry Eye Completed NCT04831177
41 Correction of Hyperopia in Children Study Completed NCT00472212
42 Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism. Completed NCT00766168
43 A Prospective, Randomized, Multicenter Trial To Evaluate The Safety And Effectiveness Of The MEL 80 Excimer Laser Using LASIK (Laser In Situ Keratomileusis) For The Correction Of ≤ +6.0 D Of Hyperopia With Or Without Astigmatism Of +0.50 D To +3.50 D And MRSE ≤ +6.50 D Completed NCT00762281
44 Detection of Hyperopia by Photoscreener GoCheckKids With Glow Fixation Device Completed NCT04297969
45 Glasses Versus Observation for Moderate Hyperopia in Young Children (HTS1) Completed NCT01515475
46 Pilot Dispensing Evaluation of a Plus Power Lens Completed NCT01228591
47 Clinical Performance of the Clariti Monthly Contact Lens for Daily Wear Completed NCT01392950
48 The Clinical Performance of the Clariti Contact Lens (Including Handling Tint) for Daily Wear Completed NCT01996787
49 Hyperopic LASIK With Concurrent Prophylactic High-fluence Cross-linking Versus Standard LASIK Outcomes Completed NCT03224013
50 A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided Lasik Correction of Hyperopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4 IR™ Excimer Laser System Completed NCT01675479

Search NIH Clinical Center for Farsightedness

Genetic Tests for Farsightedness

Genetic tests related to Farsightedness:

# Genetic test Affiliating Genes
1 Hypermetropia 29

Anatomical Context for Farsightedness

MalaCards organs/tissues related to Farsightedness:

40
Eye, Retina, Endothelial, Pituitary

Publications for Farsightedness

Articles related to Farsightedness:

(show top 50) (show all 717)
# Title Authors PMID Year
1
A novel mutation in the GUCY2D gene responsible for an early onset severe RP different from the usual GUCY2D-LCA phenotype. 54 61
15643614 2005
2
Ophthalmic manifestations in Kabuki (make-up) syndrome: A single-center pediatric cohort and systematic review of the literature. 61
33794347 2021
3
The impact of hemodialysis on retinal and choroidal thickness in patients with chronic renal failure. 61
33740202 2021
4
Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and Management. 61
33604881 2021
5
De novo stop-loss variants in CLDN11 cause hypomyelinating leukodystrophy. 61
33313762 2021
6
Is hypermetropia regressing in accommodative esotropia? 61
33567009 2021
7
Atypical presentation of peripheral posterior lenticonus and role of multi-modal ocular imaging in its diagnosis and management. 61
33547123 2021
8
Ocular biometric measurements and optical coherence tomography parameters in children with refractive errors and emmetropia. 61
33463576 2021
9
Medical conditions of children and young people with Down syndrome. 61
33426738 2021
10
Analysis of the Refractive Profile of Children with Oculocutaneous Albinism versus an Age-Matched Non-Albino Group. 61
33447012 2021
11
Senior- Løken Syndrome: A Case Series and Review of The Reno-Retinal Phenotype and Advances of Molecular Diagnosis. 61
33512896 2021
12
Longer term outcomes following serogroup B invasive meningococcal disease. 61
33460220 2021
13
Prevalence of refractive error and visual impairment among school-age children of Hargesia, Somaliland, Somalia. 61
33226104 2020
14
Do all children need a cycloplegic refraction? A comparison of Mohindra's versus cycloplegic refraction. 61
33120640 2020
15
Intraconal Orbital Hidrocystoma in an Infant. 61
33235165 2020
16
Prevalence of Refractive Error and Visual Impairment among Rural Dwellers in Mashonaland Central Province, Zimbabwe. 61
33553844 2020
17
Corona pan(dem)ic: gateway to global surveillance. 61
33100895 2020
18
Progression Over 5 Years of Prelaminar Hyperreflective Lines to Optic Disc Drusen in the Copenhagen Child Cohort 2000 Eye Study. 61
32108119 2020
19
Vision impairment and refractive errors in refugees presenting to community optometry clinics in Victoria, Australia. 61
31773820 2020
20
Refractive surprise after cataract surgery secondary to smeared optics of swept-source optical coherence tomography biometer: a case report. 61
32859161 2020
21
Tribal Odisha Eye Disease Study (TOES) # 7. Prevalence of refractive error in children in tribal Odisha (India) school screening. 61
32709785 2020
22
Assessment of Refractive Error Changes and Factors for Decompensation in Patients With Fully Accommodative Esotropia. 61
32687205 2020
23
Acquired Comitant Esotropia in Children and Young Adults: Clinical Characteristics, Surgical Outcomes, and Association With Presumed Intensive Near Work With Digital Displays. 61
32687210 2020
24
Impact of Refractive Errors on Da Vinci SI Robotic System. 61
32831541 2020
25
The Role of Heredity and the Prevalence of Strabismus in Families with Accommodative, Partial Accommodative, and Infantile Esotropia 61
32631000 2020
26
Ophthalmic findings in neonates receiving sildenafil. 61
31916341 2020
27
Associations between Attention-Deficit/Hyperactivity Disorder and Ocular Abnormalities in Children: A Population-based Study. 61
31878821 2020
28
Refraction in Preschool Children in Kazanlak, Bulgaria. 61
32666755 2020
29
Clinical characteristics and OCT analysis of a case series of posterior microphthalmos. 61
32184046 2020
30
Is the severity of refractive error dependent on the quantity and extent of retinal laser ablation for retinopathy of prematurity? 61
31554947 2020
31
[Application of nerve block in total knee arthroplasty under general anesthesia]. 61
32351092 2020
32
The hypermetropia of count István Tisza. 61
31918863 2020
33
Accuracy of noncycloplegic photorefraction using Spot photoscreener in detecting amblyopia risk factors in preschool children in an Indian eye clinic. 61
32057013 2020
34
Incidence of Keratoconus in Refractive Surgery Population of Vojvodina - Single Center Study. 61
32410891 2020
35
p.Gly743Val Mutation in COL4A1 Is Responsible for Familial Porencephaly and Severe Hypermetropia. 61
33013618 2020
36
Wide Stromal Mapping Using an Anterior Segment Optical Coherence Tomography. 61
32210528 2020
37
Non-classical 1p36 deletion in a patient with Duane retraction syndrome: case report and literature review. 61
32939224 2020
38
Evaluation of Changes in Refractive Errors Before and After Trabeculectomy and Shunt Surgery. 61
32801983 2020
39
Inter-Ocular Asymmetry in Anterior Corneal Aberrations Using Placido Disk-Based Topography. 61
32546953 2020
40
Familial Nanophthalmos Presenting with Spontaneous Uveal Effusion Syndrome. 61
30556758 2020
41
Clinical Features of Vitreomacular Traction Syndrome with Peripheral Vitreoretinal Adhesion. 61
32095069 2020
42
A randomized clinical trial using atropine, cyclopentolate, and tropicamide to compare refractive outcome in hypermetropic children with a dark iris; skin pigmentation and crying as significant factors for hypermetropic outcome. 61
31234691 2019
43
Evidence-based preschool-age vision screening: health policy considerations. 61
31514739 2019
44
Eye Conditions in Infants and Children: Myopia and Hyperopia. 61
31454214 2019
45
Progressive High Hypermetropic Shift as a Refractive Surprise Following Glaucoma Filtration Surgery in a Phakic Child With Early-Onset Childhood Glaucoma Associated With Axenfeld-Rieger Anomaly. 61
31135590 2019
46
A novel variant of the human mitochondrial DnaJ protein, Tid1, associates with a human disease exhibiting developmental delay and polyneuropathy. 61
30770860 2019
47
Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report. 61
31345173 2019
48
Post-operative analysis of pediatric esotropia associated with high hypermetropia. 61
31262252 2019
49
Visual Outcome of Preterm Infants Screened in a Tertiary Care Hospital. 61
31619904 2019
50
Comparative study of visual dysfunctions in 6-10-year-old very preterm- and full-term-born children. 61
29916121 2019

Variations for Farsightedness

ClinVar genetic disease variations for Farsightedness:

6
# Gene Name Type Significance ClinVarId dbSNP ID Position
1 NSD1 NM_022455.4(NSD1):c.3839G>A (p.Trp1280Ter) SNV Pathogenic 159315 rs587784105 GRCh37: 5:176662864-176662864
GRCh38: 5:177235863-177235863
2 ANKRD11 NM_013275.6(ANKRD11):c.5317G>T (p.Glu1773Ter) SNV Pathogenic 242882 rs1114167291 GRCh37: 16:89347633-89347633
GRCh38: 16:89281225-89281225
3 DMBX1 NM_172225.2(DMBX1):c.352C>T (p.Arg118Trp) SNV Likely pathogenic 183286 rs730882203 GRCh37: 1:46976625-46976625
GRCh38: 1:46510953-46510953
4 FGF14 NM_004115.3(FGF14):c.486dup (p.Arg163fs) Duplication Likely pathogenic 598976 rs1566823361 GRCh37: 13:102379082-102379083
GRCh38: 13:101726732-101726733
5 overlap with 8 genes GRCh37/hg19 6p24.1-23(chr6:12536624-13968949) copy number gain Uncertain significance 523282 GRCh37: 6:12536624-13968949
GRCh38:
6 overlap with 4 genes GRCh37/hg19 5p14.3-14.2(chr5:22308420-24492723) copy number gain Uncertain significance 523302 GRCh37: 5:22308420-24492723
GRCh38:
7 SLC9A6 NM_001042537.1(SLC9A6):c.1346C>A (p.Ala449Glu) SNV Uncertain significance 523398 rs1556619324 GRCh37: X:135098913-135098913
GRCh38: X:136016754-136016754
8 TOPORS NM_005802.5(TOPORS):c.2666A>G (p.His889Arg) SNV Uncertain significance 523487 rs762457246 GRCh37: 9:32541857-32541857
GRCh38: 9:32541859-32541859

Expression for Farsightedness

Search GEO for disease gene expression data for Farsightedness.

Pathways for Farsightedness

GO Terms for Farsightedness

Biological processes related to Farsightedness according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 face morphogenesis GO:0060325 8.62 NOG ANKRD11

Sources for Farsightedness

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....